Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
Gruppo Italiano Malattie EMatologiche dell'Adulto
Merck Sharp & Dohme LLC
Galapagos NV
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
BeOne Medicines
AstraZeneca
M.D. Anderson Cancer Center
BeOne Medicines
National Institutes of Health Clinical Center (CC)
AbbVie
University of Washington
AstraZeneca
Allogene Therapeutics
Genmab
BeOne Medicines
M.D. Anderson Cancer Center
BeOne Medicines
Genmab
Genmab
Eli Lilly and Company
AstraZeneca
Weill Medical College of Cornell University
Genentech, Inc.
BeOne Medicines
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
AstraZeneca
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
AstraZeneca
Baylor College of Medicine
Acerta Pharma BV
Acerta Pharma BV
Ohio State University Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
AstraZeneca
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
City of Hope Medical Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center